Lung lymphocytes: Origin, biological functions, and laboratory techniques for their study in immune-mediated pulmonary disorders

Critical Reviews in Clinical Laboratory Sciences

Volumn 33, Issue 5, 1996, Pages 423-455

  Semenzato, Gianpietro ^a   Bortolin, Michela ^a   Facco, Monica ^a   Tassinari, Cristina ^a   Sancetta, Rosaria ^a   Agostini, Carlo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Bronchoalveolar lavage; Interstitial lung disease; Pulmonary lymphocytes

Indexed keywords

CYTOKINE; MONOCLONAL ANTIBODY;

CELL CULTURE; CELL FUNCTION; CELL SUSPENSION; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOPATHOLOGY; INTERSTITIAL LUNG DISEASE; LABORATORY; LUNG; LUNG ALVEOLUS MACROPHAGE; LUNG BIOPSY; LUNG DISEASE; LUNG LAVAGE; LYMPHATIC SYSTEM; LYMPHOCYTE; LYMPHOID CELL; MOLECULAR BIOLOGY; MOLECULAR PROBE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

EID: 0029853129     PISSN: 10408363     EISSN: None     Source Type: Journal    
DOI: 10.3109/10408369609084692     Document Type: Review

References (93)

1. Bienenstock J, Johnston N Pery DYE. Bronchial lymphoid tissue. Lab Invest 1973; 28: 686-92; 693-8.
2. Pabst R. Is BALT a major component of the human lung immune system? Immunol Today 1992; 13: 119-22.
3. Schlossman SE, Boumsell L, Gilks W, et al. eds., Leukocyte differentiation antigen database in leukocyte typing V. New York: Oxford University Press, 1994.
4. Agostini C, Chilosi M, Zambello R, et al. Pulmonary immune cells in health and disease. Lymphocytes. Eur Respir J 1993; 6: 1378-401.
5. Agostini C, Trentin L, Zambello R, et al. State of the art. HIV-1 and lung. Infectivity, pathogenic mechanisms and cellular immune response taking place in the lower respiratory tract. Am Rev Respir Dis 1993; 147: 1038-49.
6. Newbury RL, Beck JM. Immunology of the lung in HIV-infected individuals. Sem Respir Critical Care Med 1995; 16: 161-72.
7. Agostini C, Zambello R, Trentin L, et al. Cytotoxic events taking place in the lung of patients with HIV-1 infection. Evidence for an intrinsic defect of the MHC-unrestricted killing partially restored by the incubation with rIL-2. Am Rev Respir Dis 1990; 142: 516-22.
8. Kelley J. Cytokines and the lung. Am Rev Respir Dis 1990; 141: 765-88.
9. Romagnani S. Human TH1 and TH2 subsets: doubt no more. Immunol Today 1991; 12: 256-7.
10. Romagnani S. Lymphokines production by human T cells in disease states. Ann Rev Immunol 1994; 12: 227-57.
11. Walker C, Bauer W, Braun RK, et al. Activated T-cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia. Am J Respir Crit Care Med 1994; 150: 1038-48.
12. Robinson DS, Ying S, Taylor IK, et al. Evidence for a TH1 like bronchoalveolar T-cell subset and predominance of interferon gamma-gene activation in pulmonary tuberculosis. Am J Resp Crit Care Med 1994; 149: 989-93.
13. Rosen MJ. Pneumonia in patients with HIV infection. Med Clin North Am 1994; 78: 1067-79.
14. Wewers MD, Saltini C, Sellers S, et al. Evaluation of alveolar macrophages in normals and individuals with active pulmonary sarcoidosis for the spontaneous expression of the interleukin-1 beta gene. Cell Immunol 1987; 107: 479-88.
15. Agostini C, Zambello R, Sancetta R, et al. Expression of tumor necrosis factor-receptor superfamily members by lung T lymphocytes in interstitial lung diseases. Am J Respir Care Med 1996; in press.
16. Agostini C, Trentin L, Facco M, et al. Role of IL-15, IL-2, and their receptors in the development of T cell alveolitis in pulmonary sarcoidosis. J Immunol 1996; 157: 910-8.
17. Costabel U, Danel C, Haslam P, et al. European Society of Pneumology Task Group on BAL. Technical recommendations and guidelines for bronchoalveolar lavage (BAL). Eur Respir J 1989; 2: 561-85.
18. Dauber JH, Wagner M, Brunsvold S, et al. Flow cytometric analysis of lymphocyte phenotypes in bronchoalveolar lavage fluid: comparison of a two-color technique with a standard immunoperoxidase assay. Am J Respir Cell Mol Biol 1992; 7: 431-41.
19. Semenzato G, Feruglio C, Siviero F, et al. Do immunological studies help to define disease activity in sarcoidosis? Sarcoidosis 1989; 6S: 38-40.
20. + T cell subset. J Clin Invest 1986; 77: 1962-70.
21. Zambello R, Trentin L, Benetti R, et al. Expression of a functional p75 interleukin-2 receptor on lung lymphocytes from patients with HIV-1 infection. J Clin Immunol 1992; 12: 371-7.
22. Chen BDM, Mueller M Chou TH. Role of GM-CSF in the regulation of alveolar macrophage proliferation and differentiation. J Immunol 1988; 141: 139-44.
23. Agostini C, Trentin L, Zambello R, et al. Release of GM-CSF by alveolar macrophages in the lung of HIV-1-infected patients. A mechanism accounting for macrophage and neutrophil accumulation. J Immunol 1992; 149: 3379-85.
24. Zeevi A, Keenan R Duquesnoy RJ. Lung transplantation: bronchoalveolar lavage diagnosis of lung rejection. Crit Care Rep 1991; 2: 228-36.
25. Olsson M, Elvin K, Lofdahl S, et al. Detection of Pneumocystis carinii in sputum and bronchoalveolar lavage by polymerase chain reaction. J Clin Microbiol 1993; 31: 221-6.
26. Tiruviluamala P, Reichman LB. Mycobacterial infections. Immunology, diagnostic strategies and techniques, treatments, and problems. Immunol Allergy Clin North Am 1993; 13: 59-67.
27. Wakefield AE, Miller RF, Guiver LA, et al. Granulomatous Pneumocystis carinii pneumonia: DNA amplification studies on bronchoscopic alveolar lavage samples. J Clin Pathol 1994; 47: 664-6.
28. Ghossein RA, Ross DG, Salomon RN, et al. A search for mycobacterial DNA in sarcoidosis using the polymerase chain reaction. Am J Clin Pathol 1994; 101: 738-41.
29. Mangiapan G, Hance AJ. Mycobacteria and sarcoidosis: an overview and summary of recent molecular biological data. Sarcoidosis 1995; 1: 20-37.
30. Popper HH, Winter E Hofler G. DNA of mycobacterium tuberculosis in formalin-fixed, paraffin-embebbed tissue in tuberculosis and sarcoidosis detected by polymerase chain reaction. Am J Clin Pathol 1994; 101: 738-41.
31. Zambello R, Trentin L, Casorati, et al. A genotypic and phenotypic analysis of T cells proliferating in the lung of patients with active sarcoidosis. In: Grassi C, Rizzato G Pozzi E, eds. Sarcoidosis and other granulomatous disorders, Pp. 187-8. Amsterdam, Elsevier 1988.
32. Moller D, Konishi K, Saltini C, et al. Persistent and similar rearrangement of the T-cell antigen receptor beta-chain gene are present in populations of lung and blood T cells among individuals with active pulmonary sarcoidosis. Clin Res 1987; 2: 632A.
33. Trentin L, Mingone N, Zambello R, et al. Mechanisms accounting for lymphocytic alveolitis in hypersensitivity pneumonitis. J Immunol 1990; 145: 2147-54.
34. Poletti G, Patelli M, Simonetti M, et al. Immunopathological and genotypic aspects of lymphocytic interstitial pneumonitis (LIP). Sarcoidosis 1991; 8: 200.
35. Wakefield AE, Peters SE, Banerj S, et al. Pneumocystis carinii shows DNA homology with the ustomycetous red yeast fungi. Mol Microbiol 1992; 6: 1903-11.
36. Wakefield AE, Miller RF, Guiver LA, et al. Oropharingeal samples for detection of Pneumocystis carinii by DNA amplification. Q J Med 1993; 86: 401-6.
37. Peters SE, Wakefield AE, Withwell KE, et al. Pneumocystis carinii pneumonia throughbred foals: identification of genetically distinct organism by DNA amplification. J Clin Microbiol 1993; 32: 213-6.
38. + T lymphocytes in the lung of acquired immunodeficiency syndrome patients harbor human immunodeficiency virus type 1. Blood 1995; 9: 2308-14.
39. Bellocq A, Lecossier D, Pierre-Audigier C, et al. T cell receptor repertoire of T lymphocytes recovered from the lung and blood of patients with sarcoidosis. Am J Resp Crit Care Med 1994; 149: 646-54.
40. Dohi M, Yamamoto K, Masuko K, et al. Accumulation of multiple T cell clonotypes in lungs of healthy individuals and patients with pulmonary sarcoidosis. J Immunol 1994; 152: 1983-8.
41. Trentin L, Zambello R, Cerutti A, et al. Discrete usage of T-Cell Receptor Vβ regions in the lung of patients with interstitial lung disease. J Cell Biochem 1994; supplement 18D: 348 (V344).
42. + T cells in bronchoalveolar lavage fluid and peripheral blood of sarcoidosis patients. Proc Natl Acad Sci USA 1994; 91: 4965-9.
43. Chilosi M, Mombello A, Montagna L, et al. Multimarker immunohistochemical staining of calgranulins, chloroacetate esterase and S100 for simultaneous demonstration of inflammatory cells on paraffin sections. J Histochem Cytochem 1990; 38: 1669-75.
44. Menestrina F, Lestani M, Mombello A, et al. Transbronchial biopsy in sarcoidosis: the role of immunohistochemical analysis for granuloma detection. Sarcoidosis 1992; 9: 95-100.
45. Baltaro RJ, Hoffman GS, Sechler JM, et al. Immunoglobulin G antineutrophil cytoplasmic antibodies are produced in the respiratory tract of patients with Wegener's granulomatosis. Am Rev Respir Dis 1992; 143: 275-8.
46. Young KR, Rankin JA, Naegel GP, et al. Bronchoalveolar lavage cells and proteins in patients with the acquired immunodeficiency syndrome: an immunological analysis. Ann Intern Med 1985; 103: 522-33.
47. The BAL Cooperative Steering Committee. Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis, and selected comparision groups. Am Rev Respir Dis 1990; 141S: 1-200.
48. Crystal RG, Bitterman PB, Rennard SI, et al. Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract (two parts). N Engl J Med 1984; 310: 154-65; 235-44.
49. Semenzato G. Immunology of interstitial lung diseases: cellular events taking place in the lung of sarcoidosis, hypersensitivity pneumonitis and HIV infection. Eur Respir J 1991; 4: 94-102.
50. Semenzato G, Trentin L, Zambello R, et al. Different types of cytotoxic lymphocytes recovered from the lungs of patients with hypersensitivity pneumonitis. Am Rev Respir Dis 1988; 137: 70-81.
51. Leatherman JW, Michael AC, Schwartz BA, et al. Lung T cells in hypersensitivity pneumonitis. Ann Intern Med 1984; 100: 390-2.
52. Costabel U, Teschler H Guzman J. Bronchiolitis obliterans organizing pneumonia (BOOP): the cytological and immunocytological profile of bronchoalveolar lavage. Eur Respir J 1992; 5: 791-7.
53. Wallaert B, Hoorelbeke A, Sibille Y, et al. The clinical role of bronchoalveolar lavage in collagen-vascular diseases. Eur Respir Rev 1992; 2: 64-8.
54. Costabel U, Donner CF, Haslam PL, et al. Clinical role of BAL in occupational lung diseases due to mineral dust exposure. Eur Respir Rev 1992; 2: 89-96.
55. Israel-Biet D, Danel C, Costabel U, et al. The clinical role of bronchoalveolar lavage in drug-induced pneumonitis. Eur Respir Rev 1992; 2: 97-9.
56. Smiejan JM, Cosnes J, Chollet-Martin S, et al. Sarcoid-like lymphocytosis of the lower respiratory tract in patients with active Chron's disease. Ann Intent Med 1986; 104: 17-21.
57. Costabel U, Zaiss AW Guzman J. Sensitivity and specificity of BAL findings in sarcoidosis. Sarcoidosis 1992; 9: 211S-14S.
58. Agostini C, Trentin L, Zambello R, et al. CD8 alveolitis in sarcoidosis. Incidence, phenotypic and clinical features. Am J Med 1993; 95: 466-72.
59. Trentin L, Marcer G, Chilosi M, et al. Longitudinal study of alveolitis in hypersensitivity pneumonitis patients: an immunological evaluation. J All Clin Immunol 1988; 4: 577-85.
60. Costabel U, Bross KJ, Guzman J, et al. Predictive value of bronchoalveolar T cell subsets for the course of pulmonary sarcoidosis. Ann N Y Acad Sci 1986; 465: 418-26.
61. Xaubet A, Agustì C, Roca J, et al. BAL lymphocytes activation antigens and diffusing capacity are related in mild to moderate pulmonary sarcoidosis. Eur Respir J 1993; 6: 715-8.
62. Agostini C, Zambello R, Trentin L et al. γ/δ T cell receptor subsets in the lung of patients with HIV-1 infection. Cell Immunol 1994; 153: 194-205.
63. Autran B, Mayaud C, Raphael M, et al. Evidence for a cytotoxic T lymphocyte alveolitis in human immunodeficiency virus-infected patients. AIDS 1988; 2: 179-83.
64. Autran B, Sadat-Sowti B, Hadida F, et al. HIV-1 specific cytotoxic T lymphocytes against alveolar macrophages: specificities and downregulation. Res Virol 1991; 142: 113-8.
65. Semenzato G, Agostini C. HIV-related interstitial lung disease. Curr Opin Pulmon Med 1995; 1: 383-91.
66. Agostini C, Semenzato G. Does bronchoalveolar lavage analysis provide a tool to monitor disease progression or predict survival in patients with HIV-1 infection? Thorax 1994; 49: 848-51.
67. Mason GR, Hashimoto CH, Dickman PS, et al. Prognostic implications of bronchoalveolar lavage neutrophilia in patients with Pneumocystis carinii pneumonia and AIDS. Am Rev Resp Dis 1989; 139: 1336-42.
68. Jensen BN, Lisse IM, Gerstoft J, et al. Cellular profiles in bronchoalveolar lavage fluid of HIV-infected patients with pulmonary symptoms: relation to diagnosis and prognosis. AIDS 1991; 5: 527-33.
69. Agostini C, Zambello R, Trentin L, et al. Prognostic significance of the evaluation of bronchoalveolar lavage populations in patients with HIV-1 infection and pulmonary involvement. Chest 1991; 100: 1601-6.
70. Drabick JJ, Williams WJ, Tan DB, et al. CD4 lymphocyte decline and survival in human immunodeficiency virus infection. The Military Medical Consortium for Applied Retroviral Research. AIDS Res Hum Retroviruses 1992; 8: 2039-47.
71. Robinson DS, Bentley AM, Hartnell A, et al. Activated memory T helper cells in bronchoalveolar lavage fluid from patients with atopic asthma: relation to asthma symptoms, lung function, and bronchial responsiveness. Thorax 1993; 48: 26-32.
72. Azzawi M, Bradley B, Jeffery PK, et al. Identification of activated T lymphocytes and eosinophils in bronchial biopsies of stable atopic asthma. Am Rev Respir Dis 1990; 142: 1407-13.
73. Robinson DS, Hamid Q, Ying S, et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992; 326: 298-304.
74. Park CS, Lee SM, Chung SW, et al. Interleukin-2 receptor in bronchoalveolar lavage fluid from patients with bronchial asthma. Chest 1994; 106: 400-6.
75. Park CS, Lee SM, Uh ST, et al. Soluble interleukin-2 receptor and cellular profiles in bronchoalveolar lavage fluid from patients with bronchial asthma. J Allergy Clin Immunol 1993; 91: 623-33.
76. Walker C, Kaegi MK, Braun P, et al. Activated T cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity. J Allergy Clin Immunol 1991; 88: 935-42.
77. Wirchow JC Jr., Walker C, Hafner D, et al. T cells and cytokines in bronchoalveolar lavage fluid after segmental allergen provocation in atopic asthma. Am J Respir Crit Care Med 1995; 151: 960-8.
78. Del Prete GF, De Carli M, Maestrelli P, et al. Allergen exposure induces the activation of allergen-specific TH2 cells in the airway mucosa of patients with allergic respiratory disorders. Eur J Immunol 1993; 23: 1445-9.
79. Walker C, Bode E, Boer L, et al. Allergic and nonallergic asthmatic have distinct patterns of T cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Resp Dis 1992; 146: 109-15.
80. Robinson DS, Ying S, Bentley AM, et al. Relationships among numbers of bronchoalveolar lavage cells expressing messenger ribonucleic acid for cytokines, asthma symptoms, and airway methacholine responsiveness in atopic asthma. J Allergy Clin Immunol 1993; 92: 397-403.
81. Marini M, Avoni E, Hollemborg J, et al. Cytokine mRNA profile and cell activation in bronchoalveolar lavage fluid from non atopic patients with symptomatic asthma. Chest 1992; 102: 661-9.
82. Walker C, Bauer W, Braun RK, et al. Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia. Am J Respir Crit Care Med 1994; 150: 1038-48.
83. Reinsmoen NL, Bolman RM, Savick K, et al. Differentiation of class I- and class II-directed donor specific alloreactivity in bronchoalveolar lavage lymphocytes from lung transplant recipients. Transplantation 1992; 53: 181-9.
84. Rabinovich H, Zeevi A, Yousem SA, et al. Alloreactivity of lung and bronchoalveolar derived lymphocytes from pulmonary transplant patients: correlation with acute rejection and bronchiolitis obliterans. Clin Transplant 1990; 4: 376-81.
85. Groen H, Aslander M, Bootsma H, et al. Bronchoalveolar lavage cell analysis and lung function impairment in patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 1993; 94: 127-33.
86. Pan L, Diss TC, Cunningham D, et al. The bcl-2 gene in primary B cell lymphoma of mucosa-associated lymphoid tissue (MALT). Am J Pathol 1989; 135: 7-11.
87. Kerrigan DP, Irons J Chen IM. Bcl-2 gene rearrangement in salivary gland lymphoma. Am J Surg Pathol 1990; 14: 1133-8.
88. Koss MN, Hocholzer L, Nichols PW, et al. Primary non-Hodgkin's lymphoma and pseudolymphoma of lung: a study of 161 patients. Hum Pathol 1983; 14: 1024-38.
89. Fishleder A, Tubbs R, Hesse B, et al. Uniform detection of immunoglobulin-gene rearrangement in benign lymphoepithelial lesions. N Engl J Med 1987; 316: 1118-21.
90. Addis BJ, Hyjek E Isaacson PG. Primary pulmonary lymphoma: a reappraisal of its histogenesis and its relationship to pseudolymphoma and lymphoid interstitial pneumonia. Histopathology 1996; 13: 1-17.
91. Herbert A, Walters MT, Cawley MID, et al. Lymphocytic interstitial pneumonia identified as lymphoma of mucosa associated lymphoid tissue. J Pathol 1985; 146: 129-38.
92. Semenzato G, Bortolin M, Facco M, et al. Data in preparation.
93. Agostini C, et al. In preparation.